As the mercury drops and we start reaching for our scarves and slippers, there’s another reason to brace ourselves this ...

The notion that we should require placebo trials even when there's already a safe, effective vaccine goes against decades of ...

"Respiratory viral infections (RVIs) are associated with elevated cardiovascular risk; however, less is known about cardiac complications after hospitalization for respiratory syncytial virus (RSV) vs ...

Infections from respiratory syncytial virus (RSV) in children requiring primary care led to significant societal economic ...

SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the ...

In this cross-sectional study, 1 in 10 patients hospitalized for respiratory syncytial virus (RSV) had a concurrent acute ...

Infections from respiratory syncytial virus (RSV) in children requiring primary care led to significant societal economic costs from outpatient ...

Professor of epidemiology at Deakin University Catherine Bennett urged Aussies to remain up to date on their Covid vaccines. ...

As the chill of winter approaches, most of us are well-versed in the annual warnings about the flu and, more recently, ...

The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for ...

A single dose of the adult RSV vaccine RSVPreF3 OA prevented RSV–lower respiratory tract disease during 3 virus seasons in adults aged 60+.

After the FDA asked for more clinical data this month, Moderna has decided to resubmit the BLA later this year.